Watch: the CureRays® explainer series
Prefer to read? The full guide below is complete on its own, with tables you can revisit any time.
What is merkel cell carcinoma?
Merkel cell carcinoma is a rare but aggressive skin cancer that grows from Merkel cells, special cells in the top layer of the skin involved in the sense of touch. It usually appears as a firm, painless, fast-growing bump that may be red, pink, or purple, most often on sun-exposed skin of the head, neck, or arms in older adults. Because it can look harmless — sometimes mistaken for a cyst or insect bite — it is often diagnosed once it has already started to grow quickly. Two main things drive this cancer: long-term sun (ultraviolet) exposure and a common virus called the Merkel cell polyomavirus, and it is more likely in people whose immune systems are weakened. Merkel cell carcinoma tends to spread to nearby lymph nodes earlier than other skin cancers, so prompt, coordinated treatment matters. The encouraging news is that this cancer is very sensitive to both radiation and modern immunotherapy, which have greatly improved outcomes.
The main types
Doctors group merkel cell carcinoma by where it starts and how it behaves:
| Type | What it means, simply |
|---|---|
| Virus-associated Merkel cell carcinoma | Most cases carry the Merkel cell polyomavirus, which plays a role in the cancer's development. |
| UV-driven (virus-negative) Merkel cell carcinoma | Some cases are driven mainly by sun damage and carry many DNA mutations; these may respond especially well to immunotherapy. |
| Localized disease | Cancer still confined to the skin where it started — treated with surgery and usually radiation. |
| Nodal or advanced disease | Cancer that has reached lymph nodes or beyond — treated with a combination of radiation, surgery, and immunotherapy. |
Staging, in plain terms
Merkel cell carcinoma is staged using the TNM system: the size and depth of the skin Tumor, whether it has reached nearby lymph Nodes, and whether it has spread (Metastasized) to distant skin, organs, or far-away lymph nodes. Because this cancer spreads to lymph nodes early and often, doctors frequently check the nearest nodes with a sentinel lymph node biopsy even when they feel normal, since this strongly affects treatment.
| TNM | What it generally means |
|---|---|
| Stage 1 | A small skin tumor (about 2 cm or less) with no sign of spread to lymph nodes — treated with surgery, usually followed by radiation. |
| Stage 2 | A larger skin tumor (over 2 cm) without lymph node spread. |
| Stage 3 | Cancer has spread to nearby lymph nodes; treatment combines surgery and radiation, with immunotherapy considered. |
| Stage 4 | The cancer has spread to distant skin, lymph nodes, or organs — immunotherapy is the main treatment, with radiation to control specific spots. |
The standard of care
Merkel Cell Carcinoma is almost always treated by a team that may include a surgeon, a medical oncologist, and a radiation oncologist, combining therapies for the best result. The usual building blocks are:
Surgery
Removing the tumor with a margin of healthy skin is the usual first step for cancer confined to the skin. A sentinel lymph node biopsy is often done at the same time to check whether the cancer has begun to spread.
Radiation therapy
Because Merkel cell carcinoma is very radiation-sensitive, radiation to the tumor site and often the nearby lymph nodes after surgery markedly lowers the chance of return. Radiation alone can also treat the cancer when surgery isn't possible.
Immunotherapy
Medicines that unleash the immune system against the cancer have transformed treatment for advanced disease, producing durable responses in many patients and increasingly used earlier in the course.
Coordinated multidisciplinary care
Because this cancer moves quickly, the best results come from a team — dermatology, surgery, radiation oncology, and medical oncology — planning treatment together and starting promptly.
How radiation treatment works
Radiation uses focused high-energy x-rays to damage the DNA inside tumor cells so they can no longer grow and divide. Merkel cell carcinoma is one of the most radiation-sensitive cancers, which makes radiation a powerful tool against it. After surgery, targeted radiation to the tumor site — and frequently the nearby lymph nodes — substantially lowers the chance the cancer returns. When surgery isn't possible, radiation alone can control the disease, and even spots that have spread often respond quickly. Modern image-guided techniques concentrate the dose on the target while sparing surrounding healthy skin and tissue. Treatments are painless and brief, given over a series of short sessions. Side effects depend on the area treated and are usually temporary, such as skin redness, irritation, or fatigue. Increasingly, radiation is paired with immunotherapy, and together they offer strong control of this aggressive cancer.
The main ways radiation is delivered for merkel cell carcinoma:
Post-surgery (adjuvant) radiation
Targeted radiation to the area where the tumor was removed, and often the draining lymph nodes, greatly reduces the chance the cancer comes back, taking advantage of its strong sensitivity to radiation.
Definitive radiation
When surgery isn't possible or advisable, focused radiation alone can control the cancer, because Merkel cell carcinoma responds so well to it.
Palliative / spot radiation
Precise radiation can quickly shrink and relieve symptoms from deposits that have spread, often working well even at modest doses.
Latest studies shaping care
Care keeps improving — often toward getting the same excellent results with less burden on patients. A few developments:
Immunotherapy transformed advanced disease: Immune-checkpoint medicines produce lasting responses in many patients with advanced Merkel cell carcinoma, a major improvement over chemotherapy, which rarely gave durable control.[1]
Avelumab (JAVELIN) and pembrolizumab trials, New England Journal of Medicine
Radiation after surgery lowers recurrence: Adding radiation to the tumor site and lymph node area after surgery has been shown to reduce the chance of the cancer returning, reflecting how sensitive it is to radiation.[2]
NCCN Merkel cell guidelines and large registry analyses
Immunotherapy moving earlier in treatment: Trials are testing immunotherapy before or after surgery for earlier-stage Merkel cell carcinoma, aiming to prevent recurrence in this fast-moving cancer.[3]
Neoadjuvant and adjuvant immunotherapy trials, Journal of Clinical Oncology
Common questions
How is Merkel cell carcinoma different from other skin cancers? It is rarer, grows faster, and spreads to lymph nodes earlier than common skin cancers like basal or squamous cell carcinoma. Because of this, it needs prompt, coordinated treatment — but it is also very sensitive to radiation and immunotherapy, which work well against it.
Why might I need radiation after surgery? Merkel cell carcinoma is highly sensitive to radiation, and giving it after surgery to the tumor site and nearby lymph nodes substantially lowers the chance the cancer returns. For this cancer, radiation is a standard and important part of curative treatment, not just a backup.
Does the virus mean it's contagious? No. The Merkel cell polyomavirus is extremely common and harmlessly present on many people's skin; it is not spread from person to person as cancer. Only rarely, and usually combined with sun damage and a weakened immune system, does it contribute to this cancer.
References
Numbered sources for the studies cited above. Links open the primary publication on PubMed or the publisher’s site.
- Avelumab (JAVELIN) and pembrolizumab trials, New England Journal of Medicine (no indexed identifier — see your care team) ↩
- NCCN Merkel cell guidelines and large registry analyses (no indexed identifier — see your care team) ↩
- Neoadjuvant and adjuvant immunotherapy trials, Journal of Clinical Oncology (no indexed identifier — see your care team) ↩